Postdoctoral Researcher (Precision immuno-oncology)

at  KU Leuven

POSTDOCTORAL RESEARCHER (PRECISION IMMUNO-ONCOLOGY)

(ref. BAP-2025-70)
Laatst aangepast: 04/02/25
This is a unique position for a highly motivated and ambitious candidate, available at the Laboratory of Cell Stress & Immunity (CSI) in KU Leuven, for a research project focussed on creating next-generation of precision immunotherapy against metastatic colorectal cancer (CRC).
The CSI Laboratory is headed by Prof. Abhishek D. Garg and focusses on using novel reverse translational approaches powered by multi-omics and spatial mapping to solve cancer immunology & immunotherapy mysteries. Ultimately, the CSI lab aims to specialize in creating next-generation cancer immunotherapies to hasten progress in immuno-oncology and help improve therapeutic outlook for cancer patients, in close collaboration with leading researchers, immunologists, and oncologists, in Belgium and abroad. The CSI lab focusses on following (specific) research themes: cancer immunology & immunotherapy, immunology of cancer cell death, cross-species reverse translational immunology, stress or therapy-elicited immune-signaling pathways, immune cell biology, systems medicine, artificial intelligence (AI)-based immunology and biomarkers for clinical immuno-oncology.
CSI Lab regularly publishes in high-impact journals (e.g., Nature Medicine, Nature Rev Immunol, Science Advances, Science Transl Medicine), and has successfully pursued ground-breaking research that has led to high-impact valorisation (e.g., patents, initiation of early phase clinical trials and creation of spin-off company trajectories).
This project aims to utilize novel insights recently gained on targeting immuno-resistant CRC in the CSI lab and convert these into tangible precision immunotherapies for treating metastatic CRC with a clear mechanism-of-action and a tangible route toward future clinical translation. The project will integrate advanced immuno-oncology, multi-omics workflows, and translational immunotherapy. With this project we ambitiously aim to go significantly beyond the current state-of-the-art, by creating innovative immunotherapies that would be eventually ready-to-use in a clinic.
Website van de eenheid

Please refer the Job description for details